Skip to search formSkip to main contentSkip to account menu

Non-Resectable Cholangiocarcinoma

A cholangiocarcinoma that is not amenable to surgical resection.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Background: Cholangiocarcinoma is a malignant neoplasia that originates in the bile ducts. Most patients with cholangiocarcinoma… 
Review
2017
Review
2017
AIM To perform a systematic review and meta-analysis on clinical outcomes of photodynamic therapy (PDT) in non-resectable… 
Review
2016
Review
2016
Background/Aims Standard treatments are not available for hilar nonresectable cholangiocarcinoma (NCC). It is unknown whether… 
Review
2007
Review
2007
SUMMARY Photodynamic therapy (PDT) is a cancer treatment modality that combines the use of a photosensitizing agent and a… 
Review
2006
Review
2006
  • E. Rauws
  • Scandinavian journal of gastroenterology…
  • 2006
  • Corpus ID: 21087090
The prognosis of patients with an unresectable bile duct cancer is poor. In 60–70% of patients, cholangiocarcinoma is located in… 
Highly Cited
2005
Highly Cited
2005
Background: Photodynamic therapy (PDT) has demonstrated promise in the palliative treatment of advanced cholangiocarcinoma. The… 
Review
2004
Review
2004
  • M. Ortner
  • Best practice & research. Clinical…
  • 2004
  • Corpus ID: 39605889
Highly Cited
1996
Highly Cited
1996
BACKGROUND AND AIMS: Radiotherapy has been reported to be of benefit in prolonging the survival of patients with…